DiaMedica Therapeutics (DMAC) Capital Leases (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Capital Leases of $1000.0 for Q1 2026, down 90.0% on a YoY basis from $10000.0 in Q1 2025, and down 75.0% quarter-over-quarter from $4000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Capital Leases (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Capital Leases for 9 years, with the latest figure at $1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases fell 90.0% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $1000.0 (down 90.0% YoY), and the FY2025 full-year result was $4000.0, down 66.67% from the prior year.
- Capital Leases for Q1 2026 stood at $1000.0, down from $4000.0 in the prior quarter.
- The five-year high for Capital Leases was $377000.0 in Q1 2023, with the low at $1000.0 in Q4 2023.
- Historically, Capital Leases has averaged $52187.5 across 5 years, with a median of $7500.0 in 2022.
- Annual changes were most pronounced in 2023 — Capital Leases soared 5000.0% — and 2024, when it tumbled 95.52%.
- DiaMedica Therapeutics' Capital Leases stood at $4000.0 in 2022, then slumped by 75.0% to $1000.0 in 2023, then soared by 1100.0% to $12000.0 in 2024, then slumped by 66.67% to $4000.0 in 2025, then slumped by 75.0% to $1000.0 in 2026.
- The last three Capital Leases figures came in at $1000.0 (Q1 2026), $4000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 357,000.00 |
| Mar 31, 2023 | 377,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 7,000.00 |